« Back
Home /
Pozelimab Biosimilar（Anti-Complement C5 Reference Antibody）

Pozelimab Biosimilar（Anti-Complement C5 Reference Antibody）

Item no.	DCC-A832-100mg
Manufacturer	DCChemicals
CASRN	2096328-94-6
Amount	100 mg
Category	Neuroscience Neuroinflammation
Specific against	other
Available
Manufacturer - Applications	Pozelimab (REGN3918) is a fully human IgG4 anti-C5 monoclonal antibody. Pozelimab binds to C5 and C5 variants with high affinity and blocks complement-mediated hemolysis. Pozelimab can be used for the research of complement-mediated diseases.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 10/9/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer